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Predicts the Growth Rate of the Aorta in
Patients With Bicuspid Aortic ValveAlessandro Della Corte, MD, PHD,* Ciro Bancone, MD, PHD,* Marianna Buonocore, MD,*
Giovanni Dialetto, MD,* Franco E. Covino, MD,* Sabrina Manduca, MD,*
Giancarlo Scognamiglio, MD,y Veronica D’Oria, MD,* Marisa De Feo, MD, PHD*
Naples, ItalyOBJECTIVES This study sought to identify risk factors for rapid growth of the ascending aorta in
patients with bicuspid aortic valve (BAV) disease, taking into account its phenotypic variability.
BACKGROUND Phenotypic heterogeneity of BAV-related aortopathy has recently been widely
recognized. However, few studies have addressed the determinants of aortic growth so far, not distin-
guishing among morphological phenotypes.
METHODS Serial retrospective data on 133 adult outpatients with BAV undergoing echocardio-
graphic follow-up were analyzed to search for factors associated with aortic diameter growth over
time and with rapid aortic growth (ﬁfth quintile of growth rate distribution), focusing on the impact
of different valve morphotypes (i.e., cusp fusion pattern: right-left coronary [RL] and right-noncoronary
[RN]) and previously deﬁned aortic phenotypes (nondilated aorta, ascending dilation, root dilation).
RESULTS The RL pattern was present in 69% of patients with BAV and RN in 31%. At baseline, an
ascending dilation phenotype was observed in 57% of patients and a root phenotype in 13.5%. No pa-
tient with RN-BAV had a root dilation phenotype at either baseline or last examination. Follow-up time
averaged 4.0  2.7 years (535 patient-years). The mean growth rate was 0.3 mm/year at the sinuses and
0.6 mm/year at the ascending level. Aortic regurgitation predicted an increase in ascending diameter
over time (odds ratio [OR]: 2.3; p ¼ 0.03). Root phenotype at presentation, not absolute baseline diam-
eter, was an independent predictor of fast progression (>0.9 mm/year) for the ascending tract (OR: 14;
p ¼ 0.001). Fast growth was rarely seen in patients with the RL morphotype and ascending phenotype
(6% at the root and 10% at the ascending level).
CONCLUSIONS In patients with BAV, the root phenotype (aortic dilation predominantly at the si-
nuses, with normal or less dilated ascending tract) may be a marker of more severe aortopathy, warrant-
ing closer surveillance and earlier treatment. The more common ascending phenotype proved to be a
more stable disease entity, generally with slower progression. (J Am Coll Cardiol Img 2013;6:1301–10)
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AA B B R E V I A T I O N S
A N D A C R O N YM S
AR = aortic regurgitation
BAV = bicuspid aortic valv
MVP = mitral valve prolap
RL = right-left coronary
RN = right-noncoronary
STJ = sinotubular junction
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1302lthough ﬁrst pointed out as early as 1999
(1), the heterogeneity of bicuspid aortic
valve (BAV) in terms of aortopathy risk and
features remain often disregarded, both in
research and clinical guidelines (2,3). The natural
course of bicuspid aortopathy can vary, ranging
from indolent aortic diameter growth to rapid pro-
gression or earlier occurrence of life-threatening
aortic complications (4,5). So far, no established
risk marker is available to help deﬁne the prognosis
of aortopathy in individual patients with BAV,
especially in terms of expected rapidity of aortic
growth.
Two sources of BAV disease heterogeneity are
the morphology of the aortic valve and the shape of
the aorta. Valve morphology has been classiﬁed by
Sievers and Schmidtke (6) according to the number
of cusps and the pattern of congenital cusp fusion.
The 2 most frequent morphotypes are believed to
have distinct underlying developmental defects and
to potentially imply different risks and features of
aortopathy (7). There is no consensus classiﬁcatione
seof the shapes that a dilated or aneurysmal
ascending aorta can assume; the use of
different criteria and imaging methods has
led to diverging nomenclature (8–10). In
2006, based on the analysis of 552 patients
with aortic dilation, we suggested the
distinction between a “root type” of dila-
tion (i.e., with sinuses of Valsalva enlarged
to a greater extent than the tubular
portion) and an “ascending type” (i.e.,dilation predominantly located distal to the sino-
tubular junction [STJ]) (11). Subsequently, the
distinction between root phenotype and ascending
phenotype has been adopted in several studies on
BAV (8,12,13). Of note, the smooth muscle cells in
the sinus portion embryologically derive in part from
the secondary heart ﬁeld, whereas those in the
tubular tract originate from the neural crest (14).
The aim of the present retrospective longitudinal
study was to assess the determinants of bicuspid
aorta growth rates over time, focusing on the
possible impact of valve morphotypes and aortic
phenotypes on the progression of the aortopathy.
METHODS
Patient cohort. Our echocardiography database was
reviewed to select serial examinations performed in
outpatients with isolated BAV. Forty-eight percent
of patients were ﬁrst referred for symptoms, 24% for
radiological evidence of increased aortic diameter,
22% were known to have a “congenital murmur,”and none had been previously followed up system-
atically. We also included patients with undeﬁned
valve morphology at pre-operative serial echocardi-
ography (usually for severely calciﬁc stenosis) but
who later received intraoperative inspective and
pathology diagnosis of congenital BAV. Exclusion
criteria were unicuspid aortic valve, associated sig-
niﬁcant congenital or acquired cardiac diseases (e.g.,
moderate or worse dysfunction of another valve,
endocarditis, coarctation), systemic syndromes (e.g.,
Marfan, Loeys-Dietz, Ehler-Danlos, Turner), and
previous cardiac surgery. From a total of 726
echocardiograms recorded between January 2000
and May 2011 in 150 outpatients with BAV who
fulﬁlled the inclusion/exclusion criteria, 716 were
serial examinations in 143 patients with at least
1 year of follow-up. Three patients were then
excluded because of left-coronary to noncoronary
leaﬂet fusion (the rare left-noncoronary morpho-
type); another 7 were excluded because of pediatric
age at presentation. The deﬁnitive study group
included 133 patients (age range 18 to 77 years).
The study conformed to the Declaration of Hel-
sinki and received local institutional review board
approval.
Variables. Three experienced operators performed
all echocardiographic examinations. Aortic stenosis
severity was graded by integration of Doppler me-
thods, continuity equation, and planimetry; aortic
regurgitation (AR) degree was deﬁned by composite
evaluation of proximal jet width, abdominal aortic
Doppler imaging, and left ventricular end-diastolic
dimension (15,16). Bicuspidy of the aortic valve
was deﬁned by a systolic ﬁsh-mouth appearance
of the oriﬁce in parasternal short-axis views (1).
Valve morphotype (i.e., the pattern of cusp fusion)
was categorized as right-left coronary (RL) (fusion
between right and left coronary cusps) or right-
noncoronary (RN) (between right and noncoronary
cusps) (6). Initially doubtful deﬁnitions of the mor-
photype (37 patients) were resolved by collegial re-
review, cardiacmagnetic resonance, or 3-dimensional
echocardiography.
The aorta was measured twice (inner-edge to
inner-edge method) by bidimensional imaging in
parasternal long-axis views at the root (maximal
dilation of the sinuses of Valsalva), STJ, and
ascending aorta (at its maximal diameter). The
tubular tract was routinely visualized as much distally
(at least 2 to 3 cm) to the STJ as possible. A random
sample of 55 examinations was repeated by a blinded
operator, showing good reproducibility (Spearman’s r
between 0.88 and 1.0 and Bland-Altman p values
>0.05). For each patient, the expected normal aortic
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1303diameters were calculated using the Roman formulas
(17). The aorta was deﬁned as dilated if the aortic
ratio exceeded 1.15 cm, corresponding on average to
>3.8 cm, 2 SD above the mean expected diameter in
the present study population at baseline (8,18). Given
the mean body surface area (BSA) of 1.8 m2, this
deﬁnition of aortic dilation corresponded to a mean
size index of$2.1 cm/m2 (5,17).The pattern of aortic
dimensions was categorized in 3 aortic phenotypes:
no-dilation phenotype, ascending phenotype (dilated
ascending aorta with normal or less dilated root), and
root phenotype (dilated root with normal or less
dilated ascending aorta) (8). Irrespective of the
ascending dimension, a small root, deﬁned as aortic
ratio <0.9, corresponding on average to <2.9 cm,
deﬁned an aortic root smaller than normal (8).
Other variables considered included hyperten-
sion, atherosclerotic disease, chronic obstructive
pulmonary disease (COPD), mitral valve prolapse
(MVP), left ventricular ejection fraction, left ven-
tricular end-diastolic diameter, stroke volume, and
interventricular septal thickness (8). Possible pres-
ence of AR (at least moderate) plus MVP, a pre-
viously reported peculiar association (19), was also
recorded. Any increase in the degree of aortic ste-
nosis or regurgitation during follow-up was recor-
ded as well.
Outcome measures. Aortic growth rate was deﬁned
as the difference between the diameter at last control
and the diameter at presentation, divided by the
follow-up time interval in years. A progressing
aortic diameter was deﬁned as any positive growth
rate (>0 mm/year). A fast progression was deﬁned
as a growth rate falling within the ﬁfth quintile of
distribution of the growth rate variable. “Phenotype
changes” were deﬁned as changes in the pattern of
aortic dimensions leading to a shift from one aortic
phenotype to another during the follow-up. As
secondary endpoints, the rates of surgical operation
on the aorta and/or valve and of aortic compli-
cations (e.g., rupture, dissection) were assessed by
telephone interview and hospital chart review
(98.5% completeness of data).
Statistical analysis. Continuous variables were
tested for normality of distribution and accordingly
summarized as mean  SD or median (interquartile
range [IQR]) and compared between 2 or more
groups through unpaired Student t test and analysis
of variance or Mann-Whitney U test and Kruskal-
Wallis H test, respectively. The growth rate vari-
able had asymmetric distribution; however, it is
presented both as median (IQR) and as mean  SD
to allow comparison with reports in the literature.
Categorical variables are presented as n (%) andwere compared by chi-square test with the Fisher
method. Multivariable binary logistic regression
models were developed with the forward stepwise
method to predict: 1) a growth >0 at the ascending
and root level separately; and 2) a fast growth (ﬁfth
quintile) at the same levels, both in the overall
cohort and in the RL and RN groups. The valve
morphotype, the aorta phenotype, and all of the
other baseline variables listed in Table 1 were tested
for univariate association with the above dependent
variables, and those showing signiﬁcant association
were entered as covariates in logistic models, with
the follow-up time variable (as natural logarithm)
always included as well. Analysis was performed
through SPSS statistical software version 16.0
(SPSS, Chicago, Illinois); signiﬁcance level was set
at p < 0.05.
RESULTS
Valve morphotypes and aortic phenotypes at
baseline. Ninety-two patients had RL valve mor-
photype (69%) and 41 had RN morphotype (31%).
Aortic diameters at presentation are reported in
Table 1. A no-dilation phenotype was present in 39
patients (29.3%), an ascending phenotype in 76
(57.1%), and a root phenotype in 18 (13.5%).
Comparisons between valve morphotypes and
among aortic phenotypes in terms of baseline pa-
rameters are reported in Tables 1 and 2, respectively.
A signiﬁcant association of RN type with aortic
valve stenosis, female sex, MVP, and smaller di-
mensions of the aortic root was observed. The root
phenotype was consistently associated with RL-
BAV and male sex.
Follow-up data. Mean follow-up time was 4.0  2.7
years (median 3 years; IQR: 1.8 to 5.2 years),
ranging from 1 to 12 years (cumulative 535 patient-
years). Aortic diameters at last follow-up echocar-
diography were 3.7  0.6, 3.5  0.6, and 4.2 
0.7 cm at sinuses, STJ, and ascending level,
respectively. Fifty-three patients (40%: 40 with
ascending phenotype, 10 with no-dilation pheno-
type, and 3 with root phenotype) underwent sur-
gery, including isolated aortic valve replacement
(19%) or aorta replacement with or without valve
operation (21%). All other patients are still under
continuing surveillance. Aortic dissection/rupture
did not occur in this series. The mean growth rate
was 0.3 mm/year at the root (median 0 mm/year;
IQR: 0.0 to 0.4 mm/year) and 0.6 mm/year at the
ascending level (median 0.3 mm/year; IQR: 0.0 to
0.8 mm/year). The STJ growth rate was judged to
be insigniﬁcant (mean 0.09 mm/year; median





(n [ 41) p Value*
Age, yrs 46  15 46  15 47  15 0.71
Female 35 (26) 19 (21) 16 (39) 0.02
BSA, m2 1.85  0.2 1.86  0.2 1.81  0.2 0.13
Valve function <0.0001
Normal 66 (50) 54 (59) 12 (29)
Stenosis ($moderate) 32 (24) 13 (14) 19 (46)
Regurgitation ($moderate) 35 (26) 25 (27) 10 (24)
BAV stenosis (any degree) 60 (45) 33 (36) 27 (66) 0.002
BAV regurgitation (any degree) 90 (68) 64 (70) 26 (63) 0.55
Ejection fraction, % 60  5 61  5 59  6 0.11
LVEDd, cm 5.3  0.6 5.3  0.6 5.2  0.6 0.19
LVSV, ml 92  23 94  21 87  26 0.12
IVSTd, cm 1.09  0.2 1.08  0.2 1.10  0.2 0.50
COPD 6 (4.5) 4 (4) 2 (5) 0.60
Hypertension 18 (13) 13 (14) 5 (12) 0.50
Chronic obstructive arteriopathy 10 (7) 5 (5) 5 (12) 0.16
Mitral valve prolapse/billowing 28 (21) 14 (15) 14 (34) 0.014
AR þ MVP association 11 (8) 6 (6) 5 (12) 0.22
Aortic root diameter, cm 3.6  0.6 3.8  0.5 3.2  0.3 <0.0001
STJ diameter, cm 3.4  0.5 3.6  0.5 3.0  0.4 <0.0001
Ascending diameter, cm 4.1  0.7 4.2  0.7 3.9  0.7 0.029
Root relative size, cm/m2 1.9  0.3 2.1  0.3 1.8  0.2 <0.0001
Ascending relative size, cm/m2 2.2  0.4 2.3  0.5 2.2  0.4 0.22
Small aortic root 16 (12) 3 (3) 13 (32) <0.0001
Values are mean  SD or n (%). *RL versus RN (unpaired Student t or chi-square test). Italicized p values are statistically signiﬁcant.
AR þ MVP ¼ moderate or worse aortic regurgitation plus mitral valve prolapse; BAV ¼ bicuspid aortic valve; BSA ¼ body surface area; COPD ¼ chronic obstructive
pulmonary disease; IVSTd ¼ interventricular end-diastolic septum thickness; LVEDd ¼ left ventricular end-diastolic diameter; LVSV ¼ left ventricular stroke volume;
RL ¼ right-left coronary; RN ¼ right-noncoronary; STJ ¼ sinotubular junction.
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13040 mm/year; IQR: 0.0 to 0.3 mm/year); therefore, no
analysis of predictors was performed for this level.
The aortic root diameter increased over time in
41% of patients, and the ascending diameter
increased in 55%. In 32% of patients, no growth
was observed at any level. Comparisons between
BAV morphotypes and among aorta phenotypes in
terms of follow-up data are depicted in Table 3;
during comparable follow-up times, patients with
root phenotype showed signiﬁcantly higher inci-
dence of fast progression of the ascending diameter.
Predictors of aortic diameter progression in the
follow-up. In univariate analysis, length of follow-
up (p ¼ 0.012), absence of aortic stenosis (p ¼
0.021), AR þ MVP (p ¼ 0.031), and AR (any
degree; p ¼ 0.038) were signiﬁcantly associated with
a progression of the aortic root diameter. The
logistic regression model, adjusted for the follow-up
time, identiﬁed the AR þ MVP association (oddsratio [OR]: 7.5; 95% conﬁdence interval [CI]: 1.8
to 49.0; p ¼ 0.014) as an independent predictor of
root diameter increase, whereas the presence of any
degree of aortic stenosis was a protective factor
(OR: 0.2; 95% CI: 0.08 to 0.6; p ¼ 0.004). In
univariate analysis, AR þ MVP (p ¼ 0.030),
presence of AR (any degree; p ¼ 0.037), follow-up
time (p ¼ 0.04), and COPD (p ¼ 0.05) were
associated with increasing ascending diameter over
time. AR (any degree; OR: 2.3; 95% CI: 1.0 to 5.1;
p ¼ 0.03) was the only independent predictor.
Predictors of fast progression of aortic diameter. A
fast-progressing aortic diameter was deﬁned as a
growth rate falling within the top quintile of growth
rates distribution: >0.9 mm/year for the ascending
level and >0.5 mm/year for the root level. A fast
progression of the root diameter was associated
with RN valve morphotype (p ¼ 0.001) (Table 3),
smaller aortic root at baseline (3.3  0.5 vs.






(n [ 18) p Value*
Age, yrs 39  17 52  12 39  11 <0.001
Female 10 (26) 25 (33) 0 0.007
BSA, m2 1.85  0.2 1.83  0.2 1.93  0.2 0.13
RN morphotype 17 (44) 24 (32) 0 0.001
Valve function 0.17
Normal 16 (41) 40 (53) 10 (56)
Stenosis ($moderate) 13 (33) 18 (24) 1 (6)
Regurgitation ($moderate) 10 (26) 18 (24) 7 (39)
BAV stenosis (any degree) 17 (44) 41 (54) 2 (11) 0.003
BAV regurgitation (any degree) 28 (72) 47 (62) 15 (83) 0.17
Ejection fraction, % 61  4 60  6 60  8 0.42
LVEDd, cm 5.2  0.5 5.2  0.6 5.7  0.5 0.011
LVSV, ml 87  24 90  22 109  15 0.002
IVSTd, cm 1.1  0.2 1.1  0.2 1.0  0.1 0.36
COPD 0 5 (7) 1 (6) 0.26
Hypertension 1 (2.6) 14 (18) 2 (11) 0.045
Chronic obstructive arteriopathy 4 (10) 6 (8) 0 0.52
Mitral valve prolapse/billowing 12 (31) 16 (21) 0 0.016
AR þ MVP association 4 (10) 7 (9) 0 0.49
Aortic root diameter, cm 3.2  0.3 3.7  0.5 4.2  0.4 <0.0001
STJ diameter, cm 2.9  0.4 3.5  0.5 3.6  0.4 <0.0001
Ascending diameter, cm 3.2  0.3 4.6  0.5 3.8  0.5 <0.0001
Root relative size, cm/m2 1.7  0.2 2.0  0.3 2.2  0.2 <0.0001
Ascending relative size, cm/m2 1.7  0.2 2.5  0.3 2.0  0.2 <0.0001
Values are mean  SD or n (%). *Comparison among phenotypes was by analysis of variance or chi-square test. Italicized p values are statistically signiﬁcant.
Abbreviations as in Table 1.
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13053.7  0.6 cm; p ¼ 0.009), and greater left ven-
tricular end-diastolic diameter (5.5  0.6 cm vs.
5.2  0.6 cm; p ¼ 0.016). The RN fusion pattern
was a signiﬁcant independent predictor in logistic
regression (Table 4); however, in RN patients, the
mean root diameter at the end of the follow-up
was within the normal range (3.3  0.3 cm).
Signiﬁcant univariate correlates of fast increasing
ascending diameter were root phenotype (50% vs.
17% in all the other patients; p ¼ 0.006), COPD
(p ¼ 0.023), and AR (any degree; p ¼ 0.028). In
multivariate analysis, only root phenotype emerged
as an independent predictor of fast ascending
growth (Table 4). The predictors of fast aortic
growth in the 2 valve morphotype subgroups are
presented in Table 4.
Phenotypic evolution. The most common pheno-
typic combination (i.e., the RL/ascending pheno-
type) relatively rarely showed fast progression: 6%
for the root level and 10% for the ascending level.Phenotype changes during the follow-up are illus-
trated in Figure 1.
D I SCUSS ION
Most studies on the natural or clinical history of
BAV aortopathy have focused on the risk of aortic
events, including aortic dissection or rupture, sud-
den death, and surgery for aortic aneurysm (4,5).
Conversely, few small studies, mainly in pediatric
populations (18,20), have looked at aortic growth
rates. After the evidence that dissection can also
occur at small aortic diameters, the threshold di-
mension mandating surgical treatment has been
progressively lowered in ofﬁcial guidelines, whereas
the yearly growth prompting surgery has long
remained unchanged (>0.5 cm/year), without
distinction among different etiologies (21). Only
recently, earlier surgery has been recommended for
patients with aortic diameter increase >2 mm/year
Table 3. Follow-Up Data



















Follow-up, yrs 3.3 (2.0–5.3) 2.4 (1.4–4.8) 0.08 3 (1.8–5.4) 3.2 (2–5) 2.2 (1.7–5.2) 0.75
Growth rate: root, mm/year 0 (0–0.31) 0 (0–1.2) 0.05 0 (0–0.4) 0 (0–0.4) 0 (0–0.3) 0.27
Growth rate: STJ, mm/year 0 (0–0.19) 0 (0–0.28) 0.34 0 (0–0.1) 0 (0–0.5) 0 (0–0) 0.79
Growth rate:
ascending, mm/year
0.2 (0–0.68) 0.35 (0–1.3) 0.07 0.2 (0–0.6) 0.3 (0–0.7) 0.6 (0–1.3) 0.43
Progression of root diameter 37 (40) 18 (44) 0.42 16 (41) 34 (45) 5 (28) 0.45
Progression of ascending diameter 49 (53) 24 (58) 0.35 20 (51) 43 (57) 10 (56) 0.91
Fast progression of root diameter 10 (11) 15 (37) 0.001 8 (20) 14 (18) 3 (17) 0.95
Fast progression of ascending diameter 17 (18) 12 (29) 0.12 9 (24) 11 (14) 9 (50) 0.02
Increase in aortic stenosis degree 16 (17) 9 (22) 0.35 5 (13) 19 (25) 1 (6) 0.11
Increase in aortic regurgitation degree 16 (17) 6 (15) 0.45 5 (13) 14 (18) 3 (17) 0.80
Values are median (interquartile range) or n (%). Mann-Whitney and Kruskal-Wallis tests were used to compare follow-up times and growth rates; chi-square test
(with Fisher exact correction) was used to compare the percentages of progressing cases and fast progressing cases. Italicized p values are statistically signiﬁcant.
Abbreviations as in Table 1.
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1306(22). In the present series, mean growth rates fell
within the range of previously reported values
(23,24); only 7 patients (5.3%) showed an in-
crease >2 mm/year. Thus, even this cutoff might
be too high. Although typically progressive in its
nature (diameters remained stable over time in
only 32% of patients), BAV aortopathy was generally
an indolent disease, with slow mean growth rates.
Nevertheless, the mean ascending diameter increase
in our fast progression group was 2 mm/year;
therefore, our deﬁnition successfully identiﬁed pa-
tients at higher risk of requiring surgery (22).
Methods for accurate prognostic stratiﬁcation
of BAV aortopathy are not available today (2).Table 4. Multivariate Predictors of Fast Growth of the Aortic Diame
Predictor
Dependent variable: ascending tract growth rate >0.9 mm/year
All patients Root phenotype
RL type Root phenotype
RN type Aortic regurgitation (any degree)
Dependent variable: root growth rate >0.5 mm/year
All patients RN type
RL type Small aortic root*
RN type Fast progression of the ascending diamet
For each segment of the aorta (ascending and root), 3 separate logistic regression mo
BAV morphotype. In each model, among all the study variables (listed in Table 1), on
(see Results) were entered as covariates. Italicized p values are statistically signiﬁcant. *
normal value (see Methods), irrespective of the diameter at the ascending tract (a fe
CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Table 1.Factors correlated with a faster growth of the aorta
could be considered among the possible markers
of more severe aortopathy. Thanassoulis et al. (23)
identiﬁed RL pattern as a predictor of fast pro-
gression (>1.01 mm/year) of the ascending tu-
bular tract diameter in 147 patients with BAV
followed for 3.8  1.4 years, whereas Holmes et al.
(18), in 112 pediatric patients, observed signiﬁ-
cantly greater z-score increase with RN fusion.
Such contrasting results may depend on the dis-
similar ages of the cohorts and different statistical
methods employed (logistic vs. linear regression)
(18,23). The present series, although not larger
than previous ones, was the ﬁrst to distinguish notter






er 6.2 1.0–37 0.04
dels were developed: 1 for the entire cohort and 1 for each of the 2 subgroups of
ly those showing signiﬁcant univariate association with the outcome variable
Small aortic root¼ diameter at the sinuses >2 SD smaller than the mean expected
ature possibly associated with either the normal or ascending phenotypes).
Figure 1. Changes in Aortic Conﬁguration Over Time
Cases of shifting from one type of dilation to another were observed exclusively among patients with root phenotype (i.e., the ascending
diameter eventually overcame the already enlarged sinus diameter). Although length of follow-up was not standardized due to the retro-
spective design, the follow-up times were not signiﬁcantly different among phenotype groups (Table 3). RL ¼ right-left coronary; RN ¼ right-
noncoronary.
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1307only valve morphotypes but also aortic phenotypes;
notably, the 2 aortic tracts (root and tubular
ascending) had distinct determinants of both
growth and fast growth (Table 4).
The coexistence of BAV regurgitation and
MVP, an association previously pointed out byothers (19), independently predicted a growth of
the aortic root over time. This may support the
previous suggestion that AR þMVP be subtended
by a congenital weakness affecting the whole
anatomic continuity spanning from the anterior
mitral leaﬂet to the ascending aorta (25). However,
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1308a biomechanical explanation for the ﬁnding cannot
be excluded (26). Aortic valve stenosis at baseline
was conversely a predictor of stability of the root
diameter during follow-up, consistent with our
previous cross-sectional study on 280 patients with
BAV (8).
Increase of the ascending diameter over time was
predicted by AR, concurring with the results for-
warded by Roberts et al. (27), whereby loss of
medial elastic ﬁbers was more frequent in the BAV
aorta with pure AR than with stenosis. Our previous
studies had already suggested that the aortopathies
associated with BAV stenosis and regurgitation may
be subtended by disparate pathobiology mech-
anisms (28). However, those pathology studies did
not discriminate between root and ascending phe-
notypes (27,28). Patients with AR BAV should
probably be regarded as more prone to dilation
progression, and eventually, provided an adequately
long follow-up time, to aneurysm development.
Greater absolute dimensions of the vessel did not
predict fast growth of the aorta, consistent with
previous studies (18,20,23). In contrast, in the RL-
BAV patient subgroup, root diameter smaller than
expected based on age and BSA was an inde-
pendent predictor of rapid growth at the sinus level
(>0.5 mm/year). Consistently, in the overall study
population, rapid sinus growth was predicted by
RN fusion, a valve morphotype showing signiﬁ-
cantly smaller root dimensions (Table 1) like in
other series (9,20). Importantly, the mean root di-
mension in patients with RN-BAV was still in the
normal range at last follow-up, and no patient with
RN-BAV developed a root phenotype (Fig. 1).
Therefore, RN fusion might not imply an increased
risk per se; our data might have merely depicted an
inverse relation between root diameter and growth
rate, consistent with the already reported evidence
that larger diameter is associated with greater stiff-
ness, which, in turn, is correlated with lower rates of
diameter increase (29). Concordantly, in a recent
study by Fernandes et al. (20), the annual change in
aortic root z-score was signiﬁcantly greater in pa-
tients with BAV with a baseline z-score #2 than in
those with a z-score >2.
For the ascending aortic diameter, the only sig-
niﬁcant independent predictor of fast growth was
the root phenotype; at least a proportion of patients
with root phenotype tended to develop diffuse
dilation of the entire ascending aorta. This ﬁnding
supports the previously forwarded hypothesis
(8,12) that the root phenotype identiﬁes those
patients in whom the expression of some congen-
ital aortic wall defect overtakes the pathogeneticrole of the hemodynamic abnormalities inherent
to valve malformation. We observed the root
phenotype mainly in male patients, generally with
nonstenotic RL-BAV, younger age, and larger
BSA than patients with ascending phenotype.
Biner et al. (13) reported increased aortic diameters
and impaired aortic wall load-bearing properties in
ﬁrst-degree relatives of a BAV cohort featuring
an unusually high rate of root phenotype (43%). In
a small observational surgical study (12), freedom
from adverse aortic events following isolated aortic
valve replacement was signiﬁcantly lower in pa-
tients with root phenotype. Assessment of the
reason for rapid dilation of the ascending tract in
patients with root phenotype is beyond the scope
of this study; however, the present ﬁndings un-
derscore the importance of distinguishing the 2
types of aortic dilation in future basic research
studies on BAV aortopathy mechanisms.
In patients with RN-BAV morphotype, never
associated with a root phenotype in this series, AR
independently predicted fast growth of the
ascending diameter. Notably, AR is typically asso-
ciated with the root phenotype (8,12); therefore, it
could represent a surrogate marker of intrinsic aortic
wall fragility in patients with RN-BAV. We could
speculate that a gene defect possibly underlying the
“malignant” form of BAV aortopathy could be a
quantitative trait, with expression that could be
modiﬁed by interaction with valve morphotype,
yielding AR and root phenotype in patients with
RL-BAV and AR alone in patients with RN-BAV.
Study limitations. Due to the relatively small
numbers, this study remains exploratory in nature,
and conclusions need further veriﬁcation. The lack
of a left-noncoronary morphotype group must be
acknowledged. This fusion pattern is extremely rare
(2% in this cohort); without a considerably larger
sample, any signiﬁcant association with the pro-
gression of aortopathy could not be ruled out. Our
diameters may not be comparable with others’
measurements by the leading-edge to leading-edge
method; however, growth rates (and therefore our
main results) were not affected by this limitation.
Another limitation is inherent to the echocardio-
graphic method: a measurement at the distal
ascending aorta (just proximal to the brachioce-
phalic trunk) was available only in 90% of patients
and at the arch only in 61%. Due to the incom-
pleteness of data, these diameters were not included
in the analysis; however, dilation extending beyond
the mid-ascending aorta was rare (12 of 120 pa-
tients). Finally, the present study is affected by the
intrinsic referral bias that limits every study based
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1309on outpatient data. Few community-based studies
have been performed on patients with BAV (4),
none of which searched for aortic growth
predictors.
CONCLUS IONS
Within the heterogeneity of manifestations of
BAV aortopathy, the present study identiﬁed
phenotype markers predicting the progression of
the aortic diameter. Translated into clinical prac-
tice, our ﬁndings might help stratify patients topersonalize both surveillance and surgical in-
dications. In particular, the aortopathy form with
predominant dilation at the sinus level, namely the
root phenotype, may represent a higher-risk con-
dition, which deserves closer follow-up and earlier
intervention.
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